VCM
INSM icon

Versant Capital Management’s Insmed INSM Stock Holding History

Versant Capital Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.6K Sell
296
-80
-21% -$9.69K ﹤0.01% 1686
2026
Q1 		$61.5K Buy
376
+136
+57% +$20.9K 0.01% 1111
2025
Q4 		$41.8K Buy
240
+53
+28% +$9.67K 0.01% 1184
2025
Q3 		$26.9K Sell
187
-21
-10% -$2.57K ﹤0.01% 1412
2025
Q2 		$20.9K Sell
208
-490
-70% -$37.5K ﹤0.01% 1499
2025
Q1 		$53.3K Buy
698
+590
+546% +$45.1K 0.01% 833
2024
Q4 		$7.46K Hold
108
– – ﹤0.01% 1553
2024
Q3 		$7.88K Hold
108
– – ﹤0.01% 1141
2024
Q2 		$7.24K Buy
+108
New +$4.19K ﹤0.01% 1100

Other funds holding INSM

GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Versant Capital Management's INSM Position: Q2 2026 in Review

Versant Capital Management reduced its Insmed (INSM) stake by 21% in Q2 2026, selling an estimated $9.69K and leaving 296 shares worth $31.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Versant Capital Management first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $61.5K in Q1 2026. 113 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Versant Capital Management held 296 shares of Insmed worth $31.6K as of Q2 2026.
  • Versant Capital Management sold 80 Insmed shares in Q2 2026, an estimated $9.69K.
  • Insmed made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #1686 holding.
  • Versant Capital Management first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Versant Capital Management's Insmed position peaked at $61.5K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.